White Paper

A Quality by Design Approach Toward Manufacturing of Elastomeric Components

How Datwyler's most advanced manufacturing standard delivers zero-defect elastomeric components for the world's most sensitive injectable drug applications.

Status Published

Format White Paper

Language English

Access Registration Required

Access the White Paper

Resource Overview

About this White Paper

Datwyler's FirstLine® manufacturing concept represents the highest tier of the company's three-tiered production standard — Essential, Advanced, and FirstLine® — purpose-built for elastomeric components used in parenteral packaging of biologics, biosimilars, and sensitive small molecules. Grounded in a Quality by Design (QbD) philosophy and a zero-defect goal, FirstLine facilities in Belgium, India, and the USA operate under cGMP-compliant clean room conditions with full automation, 100% vision inspection, paperless production floors, and statistical process control. The platform addresses three critical pharmaceutical industry trends: the increasing complexity of injectable drug formulations and extractables/leachables (E/L) concerns, more stringent FDA and global regulatory expectations, and the need for a globally harmonized supply chain for container closure systems. Datwyler's proprietary fluoropolymer spray coating and best-in-class FM457 elastomer compound are exclusively manufactured within FirstLine, making it the preferred solution for drug manufacturers seeking the lowest particulate levels, superior chemical compatibility, and regulatory defensibility for their primary packaging components.

Datwyler's FirstLine® facilities operate on a zero-defect philosophy with 100% automated camera inspection, cGMP gowning, statistical process control, and paperless production floors — delivering ultra-low particulate levels for high-risk injectable applications.
The FM457 elastomer compound and proprietary fluoropolymer spray coating — both exclusive to FirstLine — provide industry-leading extractables/leachables profiles and eliminate the need for siliconization, making them the top choice for biologics and biosimilar packaging.
With FirstLine sites on three continents (Belgium, India, USA) using identical raw materials, processes, and specifications, Datwyler offers pharmaceutical companies a globally harmonized, risk-mitigated supply chain for container closure systems.

A Quality by Design Approach Toward Manufacturing of Elastomeric Components

About this White Paper

Download the White Paper

More Quality By Design Resources

FirstLine®: Datwyler's Most Advanced Manufacturing Standard

Advancing Injectable Drug Quality: Total Quality Management for Pharmaceutical Packaging

Five years of FirstLine® in the United States

Stay informed on Datwyler Healthcare technical resources